100 related articles for article (PubMed ID: 12611045)
1. Extracellular matrix and cardiac remodelling.
Bendall JK; Heymes C; Ratajczak P; Samuel JL
Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1226-9. PubMed ID: 12611045
[TBL] [Abstract][Full Text] [Related]
2. The dynamic interaction of the extracellular matrix in cardiac remodeling.
Goldsmith EC; Borg TK
J Card Fail; 2002 Dec; 8(6 Suppl):S314-8. PubMed ID: 12555138
[TBL] [Abstract][Full Text] [Related]
3. Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells.
Gupta V; Grande-Allen KJ
Cardiovasc Res; 2006 Dec; 72(3):375-83. PubMed ID: 17010955
[TBL] [Abstract][Full Text] [Related]
4. Cardiac remodeling and failure From molecules to man (Part II).
Fedak PW; Verma S; Weisel RD; Li RK
Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
[TBL] [Abstract][Full Text] [Related]
5. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
[TBL] [Abstract][Full Text] [Related]
6. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.
Jahanyar J; Joyce DL; Southard RE; Loebe M; Noon GP; Koerner MM; Torre-Amione G; Youker KA
J Heart Lung Transplant; 2007 Jan; 26(1):34-40. PubMed ID: 17234515
[TBL] [Abstract][Full Text] [Related]
7. Pressure overload.
Frohlich ED; Susic D
Heart Fail Clin; 2012 Jan; 8(1):21-32. PubMed ID: 22108724
[TBL] [Abstract][Full Text] [Related]
8. Involvement of NADPH oxidases in cardiac remodelling and heart failure.
Sirker A; Zhang M; Murdoch C; Shah AM
Am J Nephrol; 2007; 27(6):649-60. PubMed ID: 17901689
[TBL] [Abstract][Full Text] [Related]
9. Gi alpha 1-mediated cardiac electrophysiological remodeling and arrhythmia in hypertrophic cardiomyopathy.
Ruan H; Mitchell S; Vainoriene M; Lou Q; Xie LH; Ren S; Goldhaber JI; Wang Y
Circulation; 2007 Aug; 116(6):596-605. PubMed ID: 17646583
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: ion channel remodeling in the failing ventricle.
Nass RD; Aiba T; Tomaselli GF; Akar FG
Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):196-207. PubMed ID: 18317475
[TBL] [Abstract][Full Text] [Related]
11. Contrasting gene expression profiles in two canine models of atrial fibrillation.
Cardin S; Libby E; Pelletier P; Le Bouter S; Shiroshita-Takeshita A; Le Meur N; Léger J; Demolombe S; Ponton A; Glass L; Nattel S
Circ Res; 2007 Feb; 100(3):425-33. PubMed ID: 17234964
[TBL] [Abstract][Full Text] [Related]
12. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
[TBL] [Abstract][Full Text] [Related]
13. Matricellular proteins in the heart: possible role during stress and remodeling.
Schellings MW; Pinto YM; Heymans S
Cardiovasc Res; 2004 Oct; 64(1):24-31. PubMed ID: 15364610
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
15. Mechanical signals regulating extracellular matrix gene expression in fibroblasts.
Sarasa-Renedo A; Chiquet M
Scand J Med Sci Sports; 2005 Aug; 15(4):223-30. PubMed ID: 15998339
[TBL] [Abstract][Full Text] [Related]
16. Hypertension and heart failure: a dysfunction of systole, diastole or both?
Yip GW; Fung JW; Tan YT; Sanderson JE
J Hum Hypertens; 2009 May; 23(5):295-306. PubMed ID: 19037230
[TBL] [Abstract][Full Text] [Related]
17. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
Spinale FG
Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.
Sharma UC; Pokharel S; van Brakel TJ; van Berlo JH; Cleutjens JP; Schroen B; André S; Crijns HJ; Gabius HJ; Maessen J; Pinto YM
Circulation; 2004 Nov; 110(19):3121-8. PubMed ID: 15520318
[TBL] [Abstract][Full Text] [Related]
20. Influence of cyclical mechanical strain on extracellular matrix gene expression in human lamina cribrosa cells in vitro.
Kirwan RP; Fenerty CH; Crean J; Wordinger RJ; Clark AF; O'Brien CJ
Mol Vis; 2005 Sep; 11():798-810. PubMed ID: 16205625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
